L’imagerie de médecine nucléaire : nouveaux traceurs et techniques d’avenir

Arnold, 2000, Reduction of benzodiazepine receptor binding is related to the seizure onset zone in extratemporal focal cortical dysplasia, Epilepsia, 41, 818, 10.1111/j.1528-1157.2000.tb00248.x Biraben, 2004, PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy, Neurology, 63, 73, 10.1212/01.WNL.0000132840.40838.13 Bouilleret, 2005, Involvement of the basal ganglia in refractory epilepsy: an 18F-fluoro-L-Dopa PET study using 2 methods of analysis, J. Nucl. Med., 46, 540 Bouilleret, 2008, Basal ganglia involvement in temporal lobe epilepsy: a functional and morphologic study, Neurology, 70, 177, 10.1212/01.wnl.0000297514.47695.48 Bouilleret, 2002, Insular cortex involvement in mesiotemporal lobe epilepsy: a positron emission tomography study, Ann.Neurol., 51, 202, 10.1002/ana.10087 Chassoux, 2004, Metabolic changes and electro-clinical patterns in mesio-temporal lobe epilepsy: a correlative study, Brain, 127, 164, 10.1093/brain/awh014 1998, Guidelines for neuroimaging evaluation of patients with uncontrolled epilepsy considered for surgery, Epilepsia, 39, 1375, 10.1111/j.1528-1157.1998.tb01341.x Dupont, 1999, Association of ipsilateral motor automatisms and contralateral dystonic posturing: a clinical feature differentiating medial from neocortical temporal lobe epilepsy, Arch. Neurol., 56, 927, 10.1001/archneur.56.8.927 Dupont, 1999, In vivo imaging of muscarinic cholinergic receptors in mesial temporal lobe epilepsy with a new PET tracer: [76Br]4-bromodexetimide, J. Nucl. Med., 40, 935 Dupont, 1998, The underlying pathophysiology of ictal dystonia in temporal lobe epilepsy: an FDG-PET study, Neurology, 51, 1289, 10.1212/WNL.51.5.1289 Frost, 1988, Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy, Ann. Neurol., 23, 231, 10.1002/ana.410230304 Giovacchini, 2005, 5-HT 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction, J. Nucl. Med., 46, 1128 Hammers, 2001, Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy, Neurology, 56, 897, 10.1212/WNL.56.7.897 Hammers, 2001, Central benzodiazepine receptors in malformations of cortical development: a quantitative study, Brain, 124, 1555, 10.1093/brain/124.8.1555 Henry, 1993, In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy, Neurology, 43, 1998, 10.1212/WNL.43.10.1998 Juhasz, 2003, Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy, Neurology, 60, 960, 10.1212/01.WNL.0000049468.05050.F2 Kaneko, 2006, Pre-surgical identification of epileptogenic areas in temporal lobe epilepsy by 123I-iomazenil SPECT: a comparison with IMP SPECT and FDG PET, Nucl. Med. Commun., 27, 893, 10.1097/01.mnm.0000243380.79872.32 Koepp, 2000, 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI, Neurology, 54, 332, 10.1212/WNL.54.2.332 Koepp, 1998, In vivo [11C]flumazenil-PET correlates with ex vivo [3H]flumazenil autoradiography in hippocampal sclerosis, Ann. Neurol., 43, 618, 10.1002/ana.410430510 Koepp, 1997, Central benzodiazepine/gamma-aminobutyric acid A receptors in idiopathic generalized epilepsy: an [11C]flumazenil positron emission tomography study, Epilepsia, 38, 1089, 10.1111/j.1528-1157.1997.tb01198.x Koepp, 1997, 11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy, Neurology, 49, 764, 10.1212/WNL.49.3.764 Merlet, 2004, 5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study, Brain, 127, 900, 10.1093/brain/awh109 Merlet, 2004, Statistical parametric mapping of 5-HT1A receptor binding in temporal lobe epilepsy with hippocampal ictal onset on intracranial EEG, Neuroimage, 22, 886, 10.1016/j.neuroimage.2004.02.014 Muzik, 2000, Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy, Neurology, 54, 171, 10.1212/WNL.54.1.171 Natsume, 2003, Alpha-[11C] methyl-L-tryptophan and glucose metabolism in patients with temporal lobe epilepsy, Neurology, 60, 756, 10.1212/01.WNL.0000052682.99812.F5 Newton, 1992, Dystonia, clinical lateralization, and regional blood flow changes in temporal lobe seizures, Neurology, 42, 371, 10.1212/WNL.42.2.371 Prevett, 1995, Benzodiazepine-GABAA receptors in idiopathic generalized epilepsy measured with [11C]flumazenil and positron emission tomography, Epilepsia, 36, 113, 10.1111/j.1528-1157.1995.tb00969.x Rusu, 2005, Dystonic posturing in seizures of mesial temporal origin: electroclinical and metabolic patterns, Neurology, 65, 1612, 10.1212/01.wnl.0000184510.44808.50 Ryvlin, 1998, Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study of 100 patients, Brain, 121, 2067, 10.1093/brain/121.11.2067 Savic, 1994, In vivo demonstration of altered benzodiazepine receptor density in patients with generalised epilepsy, J. Neurol. Neurosurg. Psychiatry, 57, 797, 10.1136/jnnp.57.7.797 Savic, 1988, In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci, Lancet, 2, 863, 10.1016/S0140-6736(88)92468-3 Savic, 1995, [11C]flumazenil positron emission tomography visualizes frontal epileptogenic regions, Epilepsia, 36, 1225, 10.1111/j.1528-1157.1995.tb01066.x Semah, 2002, PET imaging in epilepsy: basal ganglia and thalamic involvement, Epileptic Disord., 4, S55 Semah, 1998, Is the underlying cause of epilepsy a major prognostic factor for recurrence?, Neurology, 51, 1256, 10.1212/WNL.51.5.1256 Theodore, 2003, Does serotonin play a role in epilepsy?, Epilepsy Curr., 3, 173, 10.1046/j.1535-7597.2003.03508.x Theodore, 2006, What does flumazenil PET add to an evaluation for temporal lobectomy?, Epilepsy Curr., 6, 30, 10.1111/j.1535-7511.2005.00088.x Theodore, 2007, Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy, Epilepsia, 48, 1526, 10.1111/j.1528-1167.2007.01089.x Theodore, 1994, Positron emission tomographic measurement of cerebral blood flow and temporal lobectomy, Ann. Neurol., 36, 241, 10.1002/ana.410360220 Toczek, 2003, PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy, Neurology, 60, 749, 10.1212/01.WNL.0000049930.93113.20